Our top pick for
Streamline Health Solutions, Inc is a health information services business based in the US. Streamline Health Solutions shares (STRM) are listed on the NASDAQ and all prices are listed in US Dollars. Streamline Health Solutions employs 78 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$0.85 - $2.35|
|50-day moving average||$2.06|
|200-day moving average||$1.77|
|Wall St. target price||$2.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.01|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Streamline Health Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Streamline Health Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Streamline Health Solutions's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 178x. In other words, Streamline Health Solutions shares trade at around 178x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Streamline Health Solutions's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $472,000.
The EBITDA is a measure of a Streamline Health Solutions's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$19.9 million|
|Gross profit TTM||$13.3 million|
|Return on assets TTM||-1.63%|
|Return on equity TTM||-12.28%|
|Market capitalisation||$90.8 million|
TTM: trailing 12 months
There are currently 114,970 Streamline Health Solutions shares held short by investors – that's known as Streamline Health Solutions's "short interest". This figure is 241.4% up from 33,677 last month.
There are a few different ways that this level of interest in shorting Streamline Health Solutions shares can be evaluated.
Streamline Health Solutions's "short interest ratio" (SIR) is the quantity of Streamline Health Solutions shares currently shorted divided by the average quantity of Streamline Health Solutions shares traded daily (recently around 3.8 million). Streamline Health Solutions's SIR currently stands at 0.03. In other words for every 100,000 Streamline Health Solutions shares traded daily on the market, roughly 30 shares are currently held short.
However Streamline Health Solutions's short interest can also be evaluated against the total number of Streamline Health Solutions shares, or, against the total number of tradable Streamline Health Solutions shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Streamline Health Solutions's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Streamline Health Solutions shares in existence, roughly 0 shares are currently held short) or 0.0037% of the tradable shares (for every 100,000 tradable Streamline Health Solutions shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Streamline Health Solutions.
Find out more about how you can short Streamline Health Solutions stock.
We're not expecting Streamline Health Solutions to pay a dividend over the next 12 months.
Over the last 12 months, Streamline Health Solutions's shares have ranged in value from as little as $0.85 up to $2.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Streamline Health Solutions's is 0.8456. This would suggest that Streamline Health Solutions's shares are less volatile than average (for this exchange).
Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers health information management; coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, such as computer-assisted coding, CDI, and abstracting and physician query; and eValuator, a cloud-based pre- and post-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration, training, electronic image conversion, audit, and database monitoring services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc.
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
Everything we know about the Soulgate IPO, plus information on how to buy in.
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
Everything we know about the FIGS IPO, plus information on how to buy in.
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.